Mariam's journey culminated in the declaration of her Shahadah on a Friday, an experience she describes as lifting a burden from her chest
Pfizer Inc has withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.
ALSO READ:
>> J&J company's single-dose vaccine seeks early approval
>> UAE plays vital role in Covid-19 vaccine distribution
The U.S. company, which was the first drugmaker to apply for emergency use authorisation of its Covid-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.
“Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” it said in a statement to Reuters.
“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”
Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper shots — one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research. Both companies had applied for approval of their vaccines after Pfizer.
India’s Central Drugs Standard Control Organisation had declined to accept Pfizer’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.
Indian health officials say they generally ask for so-called bridging trials to determine if a vaccine is safe and generates an immune response in its citizens whose genetic makeup can be different from people in Western nations. There are, however, provisions under India’s New Drugs and Clinical Trial Rules, 2019, to waive such trials in certain conditions.
Pfizer earlier told Reuters its application was supported by data from a global study that showed an overall efficacy rate of 95 per cent with no vaccine-related, serious safety concerns.
Mariam's journey culminated in the declaration of her Shahadah on a Friday, an experience she describes as lifting a burden from her chest
Nearly half of residents worry about monthly expenses, survey says — here’s what’s hitting their wallets the hardest
It was a heartbreaking finish for Multan, which lost last year's final to Lahore Qalandars by one run
This allowance will be automatically included in the monthly salary of imams of mosques and muezzins
UAE’s Grenville-Wood, who moves up to 16 in the Road to Mallorca Challenge Tour Rankings, takes on the Royal Calcutta Golf Club in the Kolkata Challenge
As many as 17 properties across the Middle East and Africa were honoured at an entertaining prize-giving ceremony aboard the historic QE2
Taliban spokesman says Pakistani aircraft bombed civilian homes in Khost and Paktika provinces, killing women and children
Halep accepted a wild card into the Miami Open after her four-year doping ban was cut to nine months by the top court for global sport